Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10763207 | Biochemical and Biophysical Research Communications | 2011 | 7 Pages |
Abstract
⺠The phosphorylation of RelA's inhibitory factor IκB and subsequent RelA activation are important to the disease process of EAE. ⺠The expression of RelA and phospho-IκB was markedly increased in the initiation and during the progression of EAE. ⺠TPCK-treated EAE mice showed lower incidence of EAE with less severe symptoms and quicker recovery than vehicle-treated EAE mice. ⺠TPCK significantly suppressed the MOG35-55-specific T cell proliferation by reducing the production of IFN-γ and IL-17 cytokines in EAE. ⺠The NF-κB cascade's activity increased gradually with the development of symptoms and brain pathology of EAE.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Insun Hwang, Danbee Ha, Ginnae Ahn, Eunjin Park, Haejin Joo, Youngheun Jee,